Brainstorm Cell Financials
| BCLI Stock | USD 1.58 0.04 2.60% |
Brainstorm |
Understanding current and past Brainstorm Cell Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brainstorm Cell's financial statements are interrelated, with each one affecting the others. For example, an increase in Brainstorm Cell's assets may result in an increase in income on the income statement.
Brainstorm Cell Stock Summary
Brainstorm Cell competes with Protalix Biotherapeutics, Corvus Pharmaceuticals, Aldeyra, Checkpoint Therapeutics, and Werewolf Therapeutics. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Brainstorm Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US10501E2019 |
| CUSIP | 10501E201 10501E300 10501E102 |
| Location | New York; U.S.A |
| Business Address | 1325 Avenue of |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.brainstorm-cell.com |
| Phone | 201 488 0460 |
| Currency | USD - US Dollar |
Brainstorm Cell Key Financial Ratios
| Return On Equity | -11.22 | ||||
| Return On Asset | -2.16 | ||||
| Target Price | 14.45 | ||||
| Number Of Employees | 29 | ||||
| Beta | 0.25 |
Brainstorm Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brainstorm Cell's current stock value. Our valuation model uses many indicators to compare Brainstorm Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brainstorm Cell competition to find correlations between indicators driving Brainstorm Cell's intrinsic value. More Info.Brainstorm Cell Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brainstorm Cell's earnings, one of the primary drivers of an investment's value.Brainstorm Cell Ther Systematic Risk
Brainstorm Cell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Brainstorm Cell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Brainstorm Cell Ther correlated with the market. If Beta is less than 0 Brainstorm Cell generally moves in the opposite direction as compared to the market. If Brainstorm Cell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Brainstorm Cell Ther is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Brainstorm Cell is generally in the same direction as the market. If Beta > 1 Brainstorm Cell moves generally in the same direction as, but more than the movement of the benchmark.
About Brainstorm Cell Financials
What exactly are Brainstorm Cell Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Brainstorm Cell's income statement, its balance sheet, and the statement of cash flows. Potential Brainstorm Cell investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Brainstorm Cell investors may use each financial statement separately, they are all related. The changes in Brainstorm Cell's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Brainstorm Cell's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Brainstorm Cell February 28, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Brainstorm Cell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brainstorm Cell Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brainstorm Cell Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Brainstorm Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brainstorm Cell's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.17 | |||
| Information Ratio | 0.0161 | |||
| Maximum Drawdown | 34.91 | |||
| Value At Risk | (7.39) | |||
| Potential Upside | 11.21 |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |